PESI

ANALYST NOTE: PESI (Perma-Fix Environmental Services, Inc.) Date: 2026-06-13 Current Price: $11.00

1. Structural Readiness

• State: Context-Only.
• Conservative Entry: Not yet defined (requires confirmed breakout above the forming resistance).
• Aggressive/Pre-Breakout Entry: Not actionable on setup alone; requires confirmation.
• Breakout Level: Not yet fired.
• Current Price: $11.00.
• Extension: Not applicable (price has not extended from a confirmed breakout).
• ATR Context: Current ATR is 6.3% (Very High). This indicates elevated volatility, which increases the risk of whipsaws during the forming phase but suggests significant potential for expansion if the breakout confirms.

2. Thesis Layer

• Thesis Classification: Tactical / Setup-Led.
• Macro Thesis: There is no named secular thesis attached to this specific setup as of 2026-06-13.
• Judgment Framework: The investment case must be judged strictly on the quality of the structural setup (the forming coil) and the immediate business fundamentals (backlog growth, capacity expansion, and cash runway). Do not invent a macro narrative. The conviction relies on the execution of the company's stated operational ramp-up and the successful navigation of its liquidity constraints.

3. Business Overview

Perma-Fix Environmental Services, Inc. operates as a U.S.-based provider of specialized environmental solutions, divided into three core divisions: Treatment, Services, and Medical.

• Treatment Division (Core Growth Engine):
• Business Model: Specializes in the handling, processing, and safe disposal of hazardous, non-hazardous, low-level radioactive, and mixed waste.
• Recent Performance: Treatment revenue increased approximately 29% year-over-year in Q1 2026, driven by higher activity levels and stronger pricing.
• Backlog Visibility: The treatment backlog increased by approximately 51% year-over-year to approximately $1.9 million in revenue (as of Q1 2026), providing improved visibility.
• Capacity Expansion:
• The PFNWR facility received a permit renewal in December 2025, tripling permitted liquid mixed waste processing capacity to 1,200,000 gallons per year and authorizing up to 175,000 tons of waste annually through macroencapsulation.
• Management anticipates the deployment of a second-generation unit in the second half of 2026 at the EWOC facility in Oak Ridge, Tennessee, which is expected to triple production capacity.
• DFLAW Program: The company is positioned to receive waste via the DFLAW liquid waste treatment process at its Northwest facility starting in May 2026. Management estimates revenue potentials of $1 million to $2 million per month beginning in Q2 2026, ramping through the year.
• Federal Exposure: Revenue from federal government entities totaled $39.2 million (63.6%) in 2025. The company is tied to a long-term remediation effort for the Hanford site, with an RFP issued in December 2025 for the retrieval of 22 tanks over the next 12 years.

• Services & Medical Divisions:
• Services: Provides technical support, radiological assessments, site surveys, and decontamination/decommissioning (D&D) services.
• Medical: Focuses on R&D for medical isotope production.
• International Growth: Revenue from foreign entities increased 163% year-over-year to approximately $6.4 million in Q1 2026, reflecting growing global demand.

4. Archetype and Conviction Analysis

• Archetype: Structurally Broken / Deep Value Recovery.
• Rationale: The company exhibits the classic characteristics of a "structurally broken" name attempting a recovery: significant historical losses, a "substantial doubt" going concern warning, and a reliance on future operational execution to stabilize the balance sheet. However, the fundamental metrics show a clear inflection point with a 51% backlog increase and 29% revenue growth in the core segment.
• Valuation & Financials:
• Losses: The company reported losses from continuing operations before tax of $7.375 million in Q1 2026. Management expects Q1 losses to likely exceed $4 million in negative EBITDA on $13 million in revenue.
• Liquidity: As of March 31, 2026, cash on hand was $6.664 million. Total liquidity (cash + borrowing availability) was approximately $10.72 million.
• Going Concern: The May 7, 2026, filing explicitly states that conditions raise "substantial doubt about the Company's ability to continue as a going concern within one year."
• Forward Estimates: The financial spine indicates a forward consensus EPS of -0.6737 for FY1 and 0.6474 for FY2, suggesting a projected path to profitability in the second year.
• Conviction Stack:
• Thesis Strength: Low (No macro thesis; purely tactical).
• Evidence Quality: High (Strong backlog growth, clear capacity expansion, specific revenue guidance).
• Structural Quality: Moderate (High volatility ATR of 6.3% suggests risk; "Structurally Broken" archetype implies binary outcomes).
• Setup Readiness: Partial (Forming coil; not yet confirmed).
• Rerating Potential: High *if* the company successfully navigates the liquidity constraint and executes the capacity ramp. The market may re-rate from a "distressed" multiple to a "growth" multiple if the backlog converts to cash flow.

5. Invalidations, Strengths, and Gaps

• What Would Invalidate the Case:
• A failure to secure the anticipated DFLAW waste streams or a delay in the Hanford RFP execution.
• A breach of the liquidity runway (cash depletion) before the FY2 profitability target is reached, forcing dilution or restructuring.
• What Would Strengthen the Case:
• A confirmed breakout above the forming resistance level.
• Confirmation of the $1M-$2M/month revenue ramp in Q2 2026.
• Positive EBITDA or narrowing losses in the subsequent quarter.
• Gaps in Evidence:
• Specific Cash Burn Rate: While total cash and liquidity are known, the precise monthly burn rate relative to the new revenue ramp is not explicitly detailed in the provided snippets, making the exact timing of the "going concern" resolution uncertain.
• Debt Covenants: The filing mentions scheduled principal payments but does not detail specific covenant thresholds that could be triggered by the current loss levels.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: low Key evidence: Treatment backlog up 51% YoY to $1.9M; Permit renewal triples PFNWR capacity to 1.2M gallons/year; Revenue from foreign entities up 163% YoY to $6.4M. Key risks: Substantial doubt about ability to continue as a going concern within one year; Q1 2026 loss of $7.375M; High volatility (ATR 6.3%) increases risk of false breakouts; Liquidity runway of ~$10.7M may be insufficient if ramp delays occur. Sizing hint: Position size must be minimal due to binary going-concern risk and high volatility; treat as a lottery ticket on execution rather than a core holding. Expected path: Management expects revenue ramp to $1M-$2M/month starting Q2 2026; capacity expansion at EWOC facility in H2 2026 should drive volume; success depends on converting backlog to cash before liquidity is exhausted. Expected horizon: 6 to 12 months (until FY2 earnings or liquidity resolution).